Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-15 Sale | 2022-05-17 9:40 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R & D Officer | 21,673 | $3.95 | $85,608 | 276,399 (Direct) | View |
| 2022-05-16 Sale | 2022-05-17 9:38 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew VP | 3,136 | $3.95 | $12,387 | 117,939 (Direct) | View |
| 2022-05-15 Sale | 2022-05-17 9:36 pm | NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. CAO | 5,841 | $3.95 | $23,072 | 170,427 (Direct) | View |
| 2022-05-15 Sale | 2022-05-17 9:35 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W CEO | 36,529 | $3.95 | $144,290 | 621,351 (Indirect Direct) | View |
| 2022-05-16 Sale | 2022-05-17 9:33 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 4,592 | $3.95 | $18,138 | 223,210 (Direct) | View |
| 2022-05-15 Sale | 2022-05-17 9:32 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M CFO COO | 17,448 | $3.95 | $68,920 | 312,905 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:20 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R & D Officer | 10,912 | $10.95 | $119,486 | 274,122 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:18 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew VP | 3,661 | $10.95 | $40,088 | 121,075 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:18 pm | NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. CAO | 2,363 | $10.95 | $25,875 | 165,318 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:16 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W CEO | 12,480 | $10.95 | $136,656 | 589,430 (Indirect Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:15 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 4,852 | $10.95 | $53,129 | 227,802 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:14 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M CFO COO | 7,579 | $10.95 | $82,990 | 301,603 (Direct) | View |
| 2021-11-16 Sale | 2021-11-18 6:06 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M CFO COO | 24,149 | $13.1 | $316,391 | 256,682 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 6:11 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R & D Officer | 20,869 | $13.16 | $274,636 | 232,084 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 6:09 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew VP | 6,564 | $13.16 | $86,382 | 86,436 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 6:08 pm | NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. CAO | 6,741 | $13.16 | $88,712 | 145,981 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 6:07 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W CEO | 42,773 | $13.16 | $562,893 | 475,860 (Indirect Direct) | View |
| 2021-11-16 Sale | 2021-11-17 6:06 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 6,061 | $13.16 | $79,763 | 194,854 (Direct) | View |
| 2021-09-22 Sale | 2021-09-24 6:14 pm | NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director | 3,665 | $17.78 | $65,164 | 46,175 (Direct) | View |
| 2021-09-22 Sale | 2021-09-24 6:13 pm | NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director | 4,600 | $17.94 | $82,524 | 306,573 (Indirect Direct) | View |
| 2021-09-22 Sale | 2021-09-24 6:12 pm | NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director | 3,665 | $17.78 | $65,164 | 52,910 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-15 Option Award | 2022-05-17 9:40 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R & D Officer | 23,950 | $0 | 276,399 (Direct) | View |
| 2022-05-15 Option Award | 2022-05-17 9:36 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. CAO | 10,950 | $0 | 170,427 (Direct) | View |
| 2022-05-15 Option Award | 2022-05-17 9:35 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W CEO | 68,450 | $0 | 621,351 (Direct) | View |
| 2022-05-15 Option Award | 2022-05-17 9:32 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M CFO COO | 28,750 | $0 | 312,905 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:28 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R & D Officer | 146,950 | $0 | 379,034 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:27 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew VP | 104,950 | $0 | 191,886 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:26 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. CAO | 58,800 | $0 | 205,281 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:25 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W CEO | 349,800 | $0 | 825,660 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:24 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 104,950 | $0 | 299,804 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:23 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M CFO COO | 146,950 | $0 | 403,182 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:11 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R & D Officer | 40,150 | $0 | 232,084 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:09 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew VP | 20,100 | $0 | 86,436 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:08 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. CAO | 14,900 | $0 | 145,981 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:07 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W CEO | 94,100 | $0 | 475,860 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:04 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M CFO COO | 40,150 | $0 | 280,831 (Direct) | View |
| 2021-11-11 Option Award | 2021-11-15 5:08 pm | N/A 2029-11-10 | NEKTAR THERAPEUTICS | NKTR | Brainard Diana Director | 55,080 | $0 | 55,080 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-09 5:05 pm | 2016-09-15 2023-09-14 | NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director | 12,500 | $0 | 293,374 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-09 5:05 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director | 12,500 | $12.8 | 293,374 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:10 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R & D Officer | 71,550 | $0 | 71,550 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:09 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew VP | 35,800 | $0 | 35,800 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:07 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. CAO | 26,600 | $0 | 26,600 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:06 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W CEO | 167,650 | $0 | 167,650 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:05 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M CFO COO | 71,550 | $0 | 71,550 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-24 6:16 pm | N/A 2029-09-21 | NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director | 30,600 | $0 | 327,950 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-24 6:16 pm | N/A 2029-09-21 | NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director | 30,600 | $0 | 301,274 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-24 6:15 pm | N/A 2029-09-21 | NEKTAR THERAPEUTICS | NKTR | EASTHAM KARIN Director | 30,600 | $0 | 54,700 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-24 6:14 pm | N/A 2029-09-21 | NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director | 30,600 | $0 | 46,175 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-24 6:13 pm | N/A 2029-09-21 | NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director | 30,600 | $0 | 306,573 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-24 6:12 pm | N/A 2029-09-21 | NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director | 30,600 | $0 | 52,910 (Direct) | View |